Tamoxifen-Induced Female Androgenetic Alopecia in a Patient with Breast Cancer

Switching from Arimidex to Raloxifene worsened hair loss despite using Dutasteride. The user added oral Minoxidil, dermastamping, and RU58841 to their regimen to address the issue.

A female experiencing hair loss while on testosterone replacement therapy is using oral Minoxidil, Spironolactone, and finasteride, but still losing hair. Suggestions include switching to dutasteride, using topical anti-androgens, and reducing Nizoral shampoo use to prevent scalp dryness.

To minimize the risk of gynecomastia while maximizing hair regrowth, some suggest using finasteride six times a week and dutasteride once, while others recommend using raloxifene or tamoxifen. Concerns about gynecomastia are common, with some users experiencing flare-ups despite low estrogen levels, and others advising caution and considering surgery if necessary.

Using a low dose of topical Tamoxifen effectively reduces gynecomastia caused by finasteride, with minimal side effects. The solution involves mixing Tamoxifen with ethanol and propylene glycol, applied daily to the chest.

Finasteride is sometimes used off-label for women with hair loss, but spironolactone is often recommended first. Minoxidil and estrogen supplements are also mentioned as treatments.

A female with PCOS and androgenetic alopecia is starting treatment with oral Minoxidil, topical Minoxidil 5% with finasteride, and plans to add mesotherapy. She previously tried anti-androgenic contraceptive pills but couldn't tolerate them and is using Myo Inositol for weight management.